# Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes

> **NCT02345239** · PHASE3 · UNKNOWN · sponsor: **Dr. Waheed Rehman** · enrollment: 14 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT02345239
- **Lead sponsor:** Dr. Waheed Rehman
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2015-06
- **Final completion:** —
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2015-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02345239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02345239, "Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02345239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*